1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase II trial of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer
    Meeting Abstract

    Saltz, L. B.; Lenz, H. J.; Hochster, H.; Wadler, S.; Hoff, P.; Kemeny, N.; Hollywood, E.; Gonen, M.; Wetherbee, S.; Chen, H.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • The AJCC staging system does not predict survival in patients receiving multimodality therapy for esophageal cancer
    Meeting Abstract

    Rizk, N. P.; Bains, M. S.; Ilson, D. H.; Minsky, B.; Rusch, V. W.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Distal cT2NO rectal cancer: Is there an alternative to abdominoperineal resection?
    Meeting Abstract

    Rengan, R.; Paty, P.; Wong, W. D.; Guillem, J.; Weiser, M.; Temple, L.; Saltz, L.; Minsky, B. D.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A phase I clinical and pharmacokinetic study of weekly docetaxel followed by flavopiridol: Promising activity in metastatic pancreatic cancer
    Meeting Abstract

    Rathkopf, D.; Fornier, M.; Shah, M. A.; Kortmansky, J.; O'reilly, E.; Winkelmann, J.; Balzano, L.; Kelsen, D. P.; Schwartz, G. K.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • The impact of physical activity on patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803
    Meeting Abstract

    Meyerhardt, J. A.; Heseltine, D.; Niedzwiecki, D.; Hollis, D.; Saltz, L. B.; Mayer, R. J.; Schilsky, R. L.; Fuchs, C. S.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A comparative assessment of the incidence of steatohepatitis seen with modern chemotherapy
    Meeting Abstract

    Leonard, G. D.; Curran, S. D.; Kemeny, N. E.; Schwartz, L. H.; Fong, Y.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A phase I trial of erlotinib, gemcitabine and radiation for patients with locally advanced, unresectable pancreatic cancer
    Meeting Abstract

    Kortmansky, J. S.; O'Reilly, E. M.; Minsky, B. D.; Puleio, S. A.; Winkelmann, J.; Kelsen, D. P.; Schwartz, G. K.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Phase I trial of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (DEX) in combination with systemic oxaliplatin (OXAL), fluorouracil (FU) plus loucovorin (LV) after resection of hepatic metastases from colorectal cancer
    Meeting Abstract

    Kemeny, N. E.; Jarnagin, W.; Gonen, M.; Haviland, D.; D'Angelica, M.; Blumgart, L.; DeMatteo, R.; Schwartz, L.; Fong, Y.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Results of a phase I, dose-escalating study of the safety, tolerability and anti-tumor activity of a single injection of a genetically engineered herpes simplex virus, NV1020, in subjects with hepatic colorectal metastases
    Meeting Abstract

    Kemeny, N.; Jarnagin, W.; Guilfoyle, B.; Tufaro, F.; Karrasch, M.; Mescheder, A.; Ries, S.; Haag, N.; Fong, Y.
    Annals of Oncology (2005)

    Fulltext@MSK | Save
  • Influence of regular aspirin use on survival for patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803
    Meeting Abstract

    Fuchs, C.; Meyerhardt, J. A.; Heseltine, D. L.; Niedzwiecki, D.; Hollis, D.; Chan, A. T.; Saltz, L. B.; Schilsky, R. L.; Mayer, R. J.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save